ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, C.M.
Right arrow Articles by Yuen, K.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, C.M.
Right arrow Articles by Yuen, K.Y.
Eur Respir J 2004; 23:802-804
Copyright ©ERS Journals Ltd 2004


Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome

C.M. Chu1, Y.Y. Leung2, J.Y.H. Hui3, I.F.N. Hung4, V.L. Chan1, W.S. Leung1, K.I. Law2, C.S. Chan3, K.S. Chan1 and K.Y. Yuen4

1 Dept of Medicine, 2 Intensive Care Unit, and 3 Dept of Radiology, United Christian Hospital, and 4 Dept of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China

CORRESPONDENCE: C.M. Chu, Division of Respiratory Medicine, Dept of Medicine, United Christian Hospital, Hong Kong SAR, China. Fax: 85 223472325 E-mail: nncmchu@netvigator.com

Keywords: Complication, coronavirus, pneumomediastinum, pneumothorax, severe acute respiratory syndrome

Received: August 22, 2003
Accepted January 22, 2004

Spontaneous pneumomediastinum (SP) unrelated to assisted ventilation is a newly recognised complication of severe acute respiratory syndrome (SARS). The objective of the present study was to examine the incidence, risk factors and the outcomes of SP in a cohort of SARS victims from a community outbreak.

Data were retrieved from a prospectively collected database of virologically confirmed SARS patients. One hundred and twelve cases were analysable, with 13 patients developing SP (11.6%) at a mean±sd of 19.6±4.6 days from symptom onset.

Peak lactate dehydrogenase level was associated with the development of SP. SP was associated with increased intubation and a trend towards death. Drainage was required in five cases. For patients who survived, the SP and/or the associated pneumothoraces took a median of 28 days (interquartile range: 15–45 days) to resolve completely.

In conclusion, spontaneous pneumomediastinum appeared to be a frequent complication of severe acute respiratory syndrome. Further research is needed to investigate its pathogenesis.




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
V. C. C. Cheng, S. K. P. Lau, P. C. Y. Woo, and K. Y. Yuen
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection
Clin. Microbiol. Rev., October 1, 2007; 20(4): 660 - 694.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
K.W. Tsang, G.C. Ooi, and P.L. Ho
Diagnosis and pharmacotherapy of severe acute respiratory syndrome: what have we learnt?
Eur. Respir. J., December 1, 2004; 24(6): 1025 - 1032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the European Respiratory Society.